Chinese(GB)     
Contact CFDA
   
HOME ABOUT CFDA WHAT'S NEW LAWS & REGULATIONS REGULATORY GUIDE DATA SEARCH SITE MAP
  Search      
Home >> What's New  
What's New
CFDA Minister Bi Jingquan meets Director of the Office of Strategic Programs of the US FDA CDER and Chair of ICH Management Committee Dr. Theresa Mullin
2017-05-22

On the afternoon of May 19, 2017, Bi Jingquan, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Dr. Theresa Mullin, Director of the Office of Strategic Programs of the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA), and chair of the Management Committee of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Both sides exchanged opinions on promoting drug innovation through regulatory reform, China joining ICH etc. Bi Jingquan delivered to Dr. Theresa Mullin a letter of congratulation to convey to the newly appointed FDA Commissioner Scott Gottlieb; Dr. Theresa Mullin hand over a greeting letter from Scott Gottlieb to Bi Jingquan. CFDA Vice Minister Wu Zhen and relevant directors of CFDA's related departments attended the meeting.

HOME | ABOUT CFDA | WHAT'S NEW | LAWS AND REGULATIONS | REGULATORY GUIDE | DATA SEARCH
| SITE MAP |
© CFDA
Constructed and Maintained by the Information Center of CFDA